Literature DB >> 5129304

The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest.

S B Hulley, J M Vogel, C L Donaldson, J H Bayers, R J Friedman, S N Rosen.   

Abstract

Five healthy young men were studied during 24-30 wk of continuous bed rest. During the first 12 wk of bed rest, untreated subjects increased calcium excretion in the urine by 109 mg/day and in the feces by 147 mg/day. The rate of total body calcium loss was 0.5-0.7% per month. Losses of central calcaneus mineral, assessed by gamma ray transmission scanning, occurred at a tenfold higher rate, whereas the mineral content of the radius did not change. Changes in phosphorus balance resembled the calcium pattern, and increased excretion of nitrogen and hydroxyproline also occurred during bed rest. Upon reambulation, the subjects' calcium balance became positive in 1 month and recovery of their calcaneus mineral was complete within 10-20 wk. Treatment with potassium phosphate supplements (1327 mg P/day) entirely prevented the hypercalciuria of bed rest, but fecal calcium tended to increase. During the first 12 wk, calcium balance was slightly less negative (mean - 193 mg/day) than during bed rest without added phosphate (mean - 267 mg/day). This effect was not seen during the second 12 wk of bed rest. The patterns of magnesium excretion were similar to those of calcium. Fecal and urinary phosphorus excretions were doubled, and phosphorus balance became positive (+ 113 mg/day). Mineral loss from the central calcaneus was similar to that of untreated subjects. It is concluded that this form of phosphate supplementation reduces urinary calcium excretion but does not prevent bone loss during bed rest.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5129304      PMCID: PMC292200          DOI: 10.1172/JCI106751

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  AN AUTOMATED PROCEDURE FOR THE DETERMINATION OF PHOSPHORUS AND ALKALINE PHOSPHATASE (BODANSKY) IN SERUM.

Authors:  N W TIETZ; A GREEN
Journal:  Clin Chim Acta       Date:  1964-04       Impact factor: 3.786

2.  METABOLIC STUDIES IN PATIENTS WITH HYPERCALCIURIA.

Authors:  A M PARFITT; B A HIGGINS; J R NASSIM; J A COLLINS; A HILB
Journal:  Clin Sci       Date:  1964-12       Impact factor: 6.124

3.  EFFECT OF HIGH PHOSPHORUS INTAKE ON CALCIUM AND PHOSPHORUS METABOLISM IN MAN.

Authors:  H Spencer; J Menczel; I Lewin; J Samachson
Journal:  J Nutr       Date:  1965-06       Impact factor: 4.798

4.  THE EFFECT OF ORAL PHOSPHATE IN PATIENTS WITH RECURRENT RENAL CALCULUS.

Authors:  N A EDWARDS; R G RUSSELL; A HODGKINSON
Journal:  Br J Urol       Date:  1965-08

5.  Nitrogen determination by a continuous digestion and analysis system.

Authors:  A FERRARI
Journal:  Ann N Y Acad Sci       Date:  1960-07-22       Impact factor: 5.691

6.  The Metabolism of Calcium in Patients with Spinal Cord Injuries.

Authors:  L W Freeman
Journal:  Ann Surg       Date:  1949-02       Impact factor: 12.969

7.  Phosphate supplementation as an adjunct in the therapy of multiple myeloma.

Authors:  R S Goldsmith; H Bartos; S B Hulley; S H Ingbar; W C Moloney
Journal:  Arch Intern Med       Date:  1968-08

8.  Effect of phosphate infusion on bone metabolism and parathyroid hormone action.

Authors:  J Feinblatt; L F Bélanger; H Rasmussen
Journal:  Am J Physiol       Date:  1970-06

9.  Estimation of changes in bone calcium content by radiographic densitometry.

Authors:  G P Ose
Journal:  Radiology       Date:  1969-10       Impact factor: 11.105

10.  The treatment of adult phosphate diabetes and Fanconi syndrome with neutral sodium phosphate.

Authors:  C Nagant de Deuxchaisnes; S M Krane
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

View more
  13 in total

1.  Age and activity effects on rate of bone mineral loss.

Authors:  D M Smith; M R Khairi; J Norton; C C Johnston
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  Bone metabolism, parathyroid hormone, and calcitonin in paraplegia.

Authors:  A Chantraine; G Heynen; P Franchimont
Journal:  Calcif Tissue Int       Date:  1979-07-03       Impact factor: 4.333

Review 3.  Immobilization osteoporosis: a review.

Authors:  P Minaire
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

Review 4.  Toward a cure for osteoporosis: reversal of excessive bone fragility.

Authors:  C H Turner
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

5.  Bone remodeling during the development of osteoporosis in paraplegia.

Authors:  A Chantraine; B Nusgens; C M Lapiere
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

6.  The effect of bedrest on adrenal function.

Authors:  C S Leach; S B Hulley; P C Rambaut; L F Dietlein
Journal:  Space Life Sci       Date:  1973 Sep-Dec

Review 7.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

8.  Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism.

Authors:  A G Need; H A Morris; M Horowitz; B E Nordin
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

9.  Skeletal calcium homeostasis and countermeasures to prevent disuse osteoporosis.

Authors:  V S Schneider; J McDonald
Journal:  Calcif Tissue Int       Date:  1984       Impact factor: 4.333

10.  Bone and soft tissue changes with oral phosphate supplements.

Authors:  G H Laflamme; J Jowsey
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.